{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:44:49Z","timestamp":1778294689857,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,2,26]],"date-time":"2002-02-26T00:00:00Z","timestamp":1014681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1038\/sj.bjc.6600166","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:16:09Z","timestamp":1031249769000},"page":"669-673","source":"Crossref","is-referenced-by-count":61,"title":["Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer"],"prefix":"10.1038","volume":"86","author":[{"given":"M B","family":"Polee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F A L M","family":"Eskens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E L","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T A W","family":"Splinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P D","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H W","family":"Tilanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Stoter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"van der Gaast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,2,26]]},"reference":[{"key":"BF6600166_CR1","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/jnci\/86.14.1086","volume":"86","author":"JA Ajani","year":"1994","unstructured":"Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP (1994) Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the oesophagus. J Natl Cancer Inst 86: 1086\u20131091","journal-title":"J Natl Cancer Inst"},{"key":"BF6600166_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0959-8049(97)00088-9","volume":"33","author":"H Bleiberg","year":"1997","unstructured":"Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, Bedenne L, Namer M, DeBesi P, Gay F, Collette L, Sahmoud T (1997) Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33: 1216\u20131220","journal-title":"Eur J Cancer"},{"issue":"Suppl 15","key":"BF6600166_CR3","first-page":"2","volume":"26","author":"WJ Blot","year":"1999","unstructured":"Blot WJ, McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26: Suppl 15 2\u20138","journal-title":"Semin Oncol"},{"issue":"Suppl 4","key":"BF6600166_CR4","first-page":"20","volume":"11","author":"PI Clark","year":"2000","unstructured":"Clark PI (2000) Medical research council randomised trial of surgery with or without pre-operative chemotherapy in resectable cancer of the oesophagus. Ann Oncol 11: Suppl 4 20","journal-title":"Ann Oncol"},{"key":"BF6600166_CR5","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.1994.12.12.2654","volume":"12","author":"EA Eisenhauer","year":"1994","unstructured":"Eisenhauer EA, ten Bokkel Huinink WW, Swenerton KD, Gianni L, Myles J, Van der Burg ME, Kerr I, Vermorken JB, Buser K, Colombo N (1994) European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 12: 2654\u20132666","journal-title":"J Clin Oncol"},{"key":"BF6600166_CR6","first-page":"12","volume":"26","author":"PC Enzinger","year":"1999","unstructured":"Enzinger PC, Ilson DH, Kelsen DP (1999) Chemotherapy in esophageal cancer. Semin Oncol 26: 12\u201320","journal-title":"Semin Oncol"},{"key":"BF6600166_CR7","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","author":"A Herskovic","year":"1992","unstructured":"Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brinle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593\u20131598","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"BF6600166_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/0959-8049(94)00497-S","volume":"31","author":"PHE Hilkens","year":"1995","unstructured":"Hilkens PHE, van der Burg MEL, Moll JWB, Planting AST, van Putten WLJ, Vecht ChJ, van den Bent MJ (1995) Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration. Eur J Cancer 31: Suppl A 678\u2013681","journal-title":"Eur J Cancer"},{"key":"BF6600166_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1200\/JCO.1998.16.5.1826","volume":"16","author":"DH Ilson","year":"1998","unstructured":"Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP (1998) Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 16: 1826\u20131834","journal-title":"J Clin Oncol"},{"key":"BF6600166_CR10","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1200\/JCO.1999.17.10.3270","volume":"17","author":"DH Ilson","year":"1999","unstructured":"Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, De Groff J, Gonzalez G, Kelsen PD (1999) Phase II trial of weekly Irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17: 3270\u20133275","journal-title":"J Clin Oncol"},{"key":"BF6600166_CR11","first-page":"316","volume":"6","author":"DH Ilson","year":"2000","unstructured":"Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, Kelsen DP (2000) A Phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 6: 316\u2013323","journal-title":"Cancer J"},{"key":"BF6600166_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0002-9440(10)65346-1","volume":"154","author":"J Jankowski","year":"1999","unstructured":"Jankowski J, Wright NA, Meltzer S, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999) Molecular evolution of the metaplasia dysplasia adenoma sequence in the esophagus (MCS). Am J Pathol 154: 965\u2013974","journal-title":"Am J Pathol"},{"key":"BF6600166_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1200\/JCO.1990.8.8.1352","volume":"8","author":"DP Kelsen","year":"1990","unstructured":"Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, Bains M, Burt M, Heelan R, Hilaris B (1990) Preoperative therapy for esophageal cancer: a randomisised comparison of chemotherapy versus radiotherapy. J Clin Oncol 8: 1352\u20131361","journal-title":"J Clin Oncol"},{"issue":"Suppl 19","key":"BF6600166_CR14","first-page":"77","volume":"24","author":"DP Kelsen","year":"1997","unstructured":"Kelsen DP, Ginsberg R, Bains M, Cooper J, Arquette M, Forastiere AA, Ilson D (1997) A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. Semin Oncol 24: Suppl 19 77\u201381","journal-title":"Semin Oncol"},{"key":"BF6600166_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","volume":"339","author":"DP Kelsen","year":"1998","unstructured":"Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979\u20131984","journal-title":"N Engl J Med"},{"key":"BF6600166_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/bjc.1996.469","volume":"74","author":"TC Kok","year":"1996","unstructured":"Kok TC, Van der Gaast A, Dees J, Eijkenboom WMH, van Overhagen H, Stoter G, Tilanus HW, Splinter TAW (1996) Cisplatin and etoposide in esophageal cancer: a phase II study. Br J Cancer 74: 980\u2013984","journal-title":"Br J Cancer"},{"key":"BF6600166_CR17","first-page":"984","volume":"17","author":"TC Kok","year":"1997","unstructured":"Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW (1997) Neoadjuvant chemotherapy in operable squamous cell cancer: final report of a phase III multicenter randomised trial. Proc Am Soc Clin Oncol 17: 984","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600166_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825\u2013831","journal-title":"N Engl J Med"},{"key":"BF6600166_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archsurg.1995.01430060055011","volume":"130","author":"KW Millikan","year":"1995","unstructured":"Millikan KW, Silverstein J, Hart V, Blair K, Bines S, Roberts J, Doolas A (1995) A 15-year review of oesophagectomy for carcinoma of the esophagus and cardia. Arch Surg 130: 617\u2013624","journal-title":"Arch Surg"},{"key":"BF6600166_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/bjc.1998.524","volume":"78","author":"S Petrasch","year":"1998","unstructured":"Petrasch S, Welt A, Reinacher A, Graeven U, K\u00f6nig M, Schmiegel W (1998) Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer. Br J Cancer 78: 511\u2013514","journal-title":"Br J Cancer"},{"key":"BF6600166_CR21","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2070::AID-CNCR6>3.0.CO;2-S","volume":"78","author":"CH Spiridonidis","year":"1996","unstructured":"Spiridonidis CH, Laufman LR, Jones JJ, Gray DJ, Cho CC, Young DC (1996) A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma. Cancer 78: 2070\u20132077","journal-title":"Cancer"},{"key":"BF6600166_CR22","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/sj.bjc.6690462","volume":"80","author":"A Van der Gaast","year":"1999","unstructured":"Van der Gaast A, Kok TC, Kerkhofs L, Siersema PD, Tilanus HW, Splinter TAW (1999) Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer. Br J Cancer 80: 1052\u20131057","journal-title":"Br J Cancer"},{"key":"BF6600166_CR23","unstructured":"World Health Organization (1979) WHO handbook for reporting results of cancer treatment WHO Offset Publ. No. 4 Geneva: World Health Organization"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:41:23Z","timestamp":1684413683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,26]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["BF6600166"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600166","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,26]]}}}